A Double-Blind Safety and Efficacy Study of GSK2894512 Cream Versus Vehicle in the Treatment of Adult Plaque Psoriasis
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 18 Jan 2019
At a glance
- Drugs Tapinarof (Primary)
- Indications Plaque psoriasis
- Focus Registrational; Therapeutic Use
- Sponsors GlaxoSmithKline
- 06 Dec 2017 Planned primary completion date changed from 26 Apr 2018 to 28 Sep 2018.
- 06 Dec 2017 Planned initiation date changed from 1 Feb 2018 to 22 Jan 2018.
- 06 Dec 2017 Status changed from not yet recruiting to withdrawn prior to enrolment.